GeneDx has announced its intention to acquire Fabric Genomics, a move that positions it to advance in the field of genomic ...

Despite major product launches from diabetes rivals last year, Abbott’s diabetes unit brought in $1.8bn total Q1 sales to ...

Verafeye is a four-dimensional (4D), ultrasound-based cardiac visualisation and navigation platform that generates a ...

Health Canada has granted approval for NanoSpeed Diagnostics’ Test4D Serum, designed to identify Vitamin D levels in blood ...

Genesis has gained US Food and Drug Administration (FDA) clearance on an Investigational New Drug (IND) application for a ...

The US Food and Drug Administration (FDA) has granted marketing authorisation for ActiveProtective Technologies’ (APT) Tango ...

Cadwell Industries has made a strategic investment in the Australian company Seer Medical, which specialises in epilepsy ...

The coronary stent market in the Asia-Pacific (APAC) region is witnessing sustained growth, driven by rising coronary artery ...

The University of Birmingham has secured £230,00 ($303,000) in funding from Cancer Research Horizons towards the development ...

Edwards’ device, dubbed Sapien M3, is the first approved system to use a transfemoral approach to treating mitral ...

Researchers from Weill Cornell Medicine (WCM) and New York Genome Center (NYGC), US, have identified an “accurate” and ...

Dutch diagnostics company Inbiome has secured the EU's In Vitro Diagnostic Regulation (IVDR) certification for its rapid ...